120 related articles for article (PubMed ID: 17494642)
1. 6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats.
Wong H; Dockens RC; Pajor L; Yeola S; Grace JE; Stark AD; Taub RA; Yocca FD; Zaczek RC; Li YW
Drug Metab Dispos; 2007 Aug; 35(8):1387-92. PubMed ID: 17494642
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats.
Zuideveld KP; Rusiç-Pavletiç J; Maas HJ; Peletier LA; Van der Graaf PH; Danhof M
J Pharmacol Exp Ther; 2002 Dec; 303(3):1130-7. PubMed ID: 12438536
[TBL] [Abstract][Full Text] [Related]
3. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.
Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD
Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925
[TBL] [Abstract][Full Text] [Related]
5. Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: raphé control of somatodendritic and terminal 5-HT release.
Matos FF; Urban C; Yocca FD
J Neural Transm (Vienna); 1996; 103(1-2):173-90. PubMed ID: 9026372
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of the 5-HT(1A) receptor agonist buspirone on stress-induced hyperglycemia in mice: involvement of insulin and a buspirone metabolite, 1-(2-pyrimidinyl)piperazine (1-PP).
Sugimoto Y; Takashima N; Noma T; Yamada J
Biol Pharm Bull; 2005 Apr; 28(4):733-5. PubMed ID: 15802819
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
Meller E; Li H; Carr KD; Hiller JM
J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
[TBL] [Abstract][Full Text] [Related]
8. The influences of aconitine, an active/toxic alkaloid from aconitum, on the oral pharmacokinetics of CYP3A probe drug buspirone in rats.
Zhu L; Lu L; Guo E; Wu J; Wang Y; Hu M; Liu Z
Drug Metab Lett; 2014; 8(2):135-44. PubMed ID: 25434398
[TBL] [Abstract][Full Text] [Related]
9. Agonist-dependent modulation of G-protein coupling and transduction of 5-HT1A receptors in rat dorsal raphe nucleus.
Valdizán EM; Castro E; Pazos A
Int J Neuropsychopharmacol; 2010 Aug; 13(7):835-43. PubMed ID: 19895724
[TBL] [Abstract][Full Text] [Related]
10. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
11. Agonists at the serotonin receptor (5-HT(1A)) protect the retina from severe photo-oxidative stress.
Collier RJ; Patel Y; Martin EA; Dembinska O; Hellberg M; Krueger DS; Kapin MA; Romano C
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2118-26. PubMed ID: 21087971
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous quantitation of buspirone and its major metabolite 1-(2-pyrimidinyl)piperazine in human plasma by high-performance liquid chromatography with coulometric detection.
Odontiadis J; Franklin M
J Pharm Biomed Anal; 1996 Jan; 14(3):347-51. PubMed ID: 8851759
[TBL] [Abstract][Full Text] [Related]
13. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
14. Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats.
Fuller RW; Perry KW
J Pharmacol Exp Ther; 1989 Jan; 248(1):50-6. PubMed ID: 2521515
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924.
Newman-Tancredi A; Rivet JM; Cussac D; Touzard M; Chaput C; Marini L; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep; 368(3):188-99. PubMed ID: 12923612
[TBL] [Abstract][Full Text] [Related]
16. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
[TBL] [Abstract][Full Text] [Related]
17. 5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies.
Piñeyro G; de Montigny C; Blier P
Neuropsychopharmacology; 1995 Nov; 13(3):249-60. PubMed ID: 8602897
[TBL] [Abstract][Full Text] [Related]
18. The effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of buspirone.
Lamberg TS; Kivistö KT; Laitila J; Mårtensson K; Neuvonen PJ
Eur J Clin Pharmacol; 1998; 54(9-10):761-6. PubMed ID: 9923581
[TBL] [Abstract][Full Text] [Related]
19. Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze.
Cao BJ; Rodgers RJ
Neuropharmacology; 1997 Aug; 36(8):1089-97. PubMed ID: 9294974
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of 6-hydroxybuspirone and its enantiomers administered individually or following buspirone administration in humans.
Dockens RC; Tran AQ; Zeng J; Croop R
Biopharm Drug Dispos; 2007 Oct; 28(7):393-402. PubMed ID: 17668416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
